< Back to latest news & events

News

Update on G1/22 and G2/22

April 2022

In our previous article we discussed the referral to the Enlarged Board of Appeal regarding questions on entitlement to priority (G1/22 and G2/22).

The EPO has now implemented a stay on any proceedings which are dependent on the outcome of the questions posed to the Enlarged Board of Appeal.

The stay concerns examination and opposition proceedings where the entitlement to claim priority as successor in title under Article 87(1) EPC is relevant for the division’s decision and there is no evidence (beyond a possible PCT request) that the priority right was transferred from the applicant of the priority application to the applicant of the application in question before the filing date of the latter.

If proceedings are stayed, the examining or opposition division will inform the parties accordingly. In addition, there will be no communications setting time limits to reply , or any further communication until the Enlarged Board of Appeal has issued its decision. Once a decision has been made, parties will be notified regarding resumption of the proceedings.


This update was prepared by HGF Professional Standards Officer Dr Edward Pullicino.

Latest updates

IAM Patent 1000 2023

IAM Patent 1000 the world’s leading patent professionals 2023 guide has now been published and we are delighted to have 31 attorneys recognised as world-class individuals in the guide. The …

Read article
Event - 26th September 2023

Bioforward OBN Conference 2023

Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …

Event details
Event - 28th-30th November 2023

IPBC Asia event

The IPBC Asia event is due to go ahead on 28th-30th November, at The Palace Hotel in Tokyo. This event will have experts from the IP market attending and sharing …

Event details

AI-Powered Personalised Medicine

The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …

Read article